BriaCell Therapeutics (BCTX) vs Rockwell Medical (RMTI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Rockwell Medical (RMTI) has outperformed BriaCell Therapeutics (BCTX) over the past year, losing 30.9% versus a loss of 68.3%. Over five years, RMTI leads with a -87.5% price change compared with -95.1% for BCTX. BriaCell Therapeutics is the larger company by market cap ($34.8 million vs $33.1 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BCTX | RMTI |
|---|---|---|
| Share price | $4.00 | $8.22 |
| Market cap | $34.80M | $33.13M |
| 1-day change | -0.50% | +7.59% |
| YTD return | -43.74% | -0.96% |
| 1-year return | -68.33% | -30.92% |
| 5-year return | -95.12% | -87.55% |
| Forward P/E | — | 117.43 |
| EPS (TTM) | $-0.92 | $-1.34 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $14.68 | $12.90 |
| 52-week low | $2.60 | $4.89 |
| Distance from 52-week high | -72.75% | -36.28% |
| Average volume | 284.64K | 26.39K |
| Shares outstanding | 8.70M | 4.03M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- RMTI has outperformed BCTX by 37.4 percentage points over the past year.
BCTX vs RMTI FAQ
Which is bigger, BriaCell Therapeutics or Rockwell Medical?
BriaCell Therapeutics (BCTX) is larger, with a market capitalization of $34.80M compared with $33.13M for Rockwell Medical (RMTI).
Which stock has performed better over the past year, BCTX or RMTI?
RMTI returned -30.92% over the past 12 months, compared with -68.33% for BCTX (price return, excluding dividends). Past performance does not predict future results.
Are BriaCell Therapeutics and Rockwell Medical in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.